Indoco Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
250.65
21.97 (9.61%)
BSENSE

May 07

BSE+NSE Vol: 14.88 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
475.61
445.36
484.67
439.67
390.21
410.55
432.66
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
475.61
445.36
484.67
439.67
390.21
410.55
432.66
Raw Material Cost
109.18
97.89
112.99
105.53
85.86
109.91
94.27
Purchase of Finished goods
32.52
32.99
38.82
39.23
30.62
34.93
39.14
(Increase) / Decrease In Stocks
-0.69
-10.46
-6.47
-9.79
-10.51
-30.92
3.39
Employee Cost
109.41
106.03
103.23
107.02
106.32
97.55
92.88
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
17.76
18.31
21.81
21.66
17.39
18.66
15.27
Other Expenses
157.72
169.09
171.24
158.49
161.31
168.39
147.46
Total Expenditure (Excl Depreciation)
425.90
413.85
441.62
422.14
390.99
398.52
392.41
Operating Profit (PBDIT) excl Other Income
49.71
31.51
43.05
17.53
-0.78
12.03
40.25
Other Income
-0.04
0.98
0.76
1.63
2.02
0.85
1.56
Operating Profit (PBDIT)
49.67
32.49
43.81
19.16
1.24
12.88
41.81
Interest
45.92
25.64
24.56
26.12
17.98
16.11
17.83
Exceptional Items
3.74
-6.15
-0.53
0.00
0.00
0.99
0.00
Gross Profit (PBDT)
7.49
0.70
18.72
-6.96
-16.74
-2.24
23.98
Depreciation
32.49
32.01
32.25
29.70
28.78
28.72
28.82
Profit Before Tax
-25.00
-31.31
-13.53
-36.66
-45.52
-30.96
-4.84
Tax
-1.32
-1.86
-4.32
-0.31
-4.18
-2.56
5.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-23.68
-29.45
-9.21
-36.35
-41.34
-28.40
-10.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-23.68
-29.45
-9.21
-36.35
-41.34
-28.40
-10.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.04
0.34
-1.28
-0.56
-0.95
-2.01
-0.44
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-21.64
-29.79
-7.93
-35.79
-40.39
-26.39
-9.57
Equity Capital
18.46
18.45
18.45
18.45
18.45
18.44
18.44
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
-2.34
-3.23
-0.86
-3.88
-4.38
-2.86
-1.04
Diluted Earnings per share
-2.56
-3.19
-1.0
-3.94
-4.48
-3.08
-1.08
Operating Profit Margin (Excl OI)
10.9%
7.25%
9.12%
4.07%
-0.2%
2.99%
9.35%
Gross Profit Margin
1.64%
0.16%
3.97%
-1.62%
-4.36%
-0.56%
5.57%
PAT Margin
-5.19%
-6.78%
-1.95%
-8.44%
-10.77%
-7.06%
-2.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 6.79% vs -8.11% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 27.36% vs -275.66% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 57.76% vs -26.81% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 79.10% vs 4.40% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Indoco Remedies With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
475.61
0
475.61
Other Operating Income
0.00
0.00
0.00
Total Operating income
475.61
0
475.61
Raw Material Cost
109.18
0
109.18
Purchase of Finished goods
32.52
0
32.52
(Increase) / Decrease In Stocks
-0.69
0
-0.69
Employee Cost
109.41
0
109.41
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
17.76
0
17.76
Other Expenses
157.72
0.00
157.72
Total Expenditure (Excl Depreciation)
425.90
0
425.90
Operating Profit (PBDIT) excl Other Income
49.71
0.00
49.71
Other Income
-0.04
0
-0.04
Operating Profit (PBDIT)
49.67
0
49.67
Interest
45.92
0
45.92
Exceptional Items
3.74
0
3.74
Gross Profit (PBDT)
7.49
0
7.49
Depreciation
32.49
0
32.49
Profit Before Tax
-25.00
0
-25.00
Tax
-1.32
0
-1.32
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-23.68
0
-23.68
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
-23.68
0
-23.68
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-2.04
0
-2.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-21.64
0
-21.64
Equity Capital
18.46
0
18.46
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
-2.34
0
-2.34
Diluted Earnings per share
-2.56
0
-2.56
Operating Profit Margin (Excl OI)
10.90%
0%
0.00
10.90%
Gross Profit Margin
1.64%
0%
0.00
1.64%
PAT Margin
-5.19%
0%
0.00
-5.19%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 475.61 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 6.79% vs -8.11% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 21.89% vs -13.22% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit -21.64 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 27.36% vs -275.66% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 46.42% vs -277.93% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 49.71 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 57.76% vs -26.81% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 6,473.08% vs -101.60% in Mar 2025

Quarterly - Interest
Interest 45.92 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 79.10% vs 4.40% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 155.39% vs 49.21% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.90%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025